AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $668,000 | +187.9% | 8,663 | +213.5% | 0.03% | +233.3% |
| Q2 2018 | $232,000 | -64.0% | 2,763 | -65.0% | 0.01% | -65.4% |
| Q1 2018 | $644,000 | -57.2% | 7,887 | -70.1% | 0.03% | -61.2% |
| Q4 2017 | $1,505,000 | +252.5% | 26,335 | +158.1% | 0.07% | +219.0% |
| Q2 2016 | $427,000 | -64.0% | 10,202 | -65.1% | 0.02% | -60.4% |
| Q1 2016 | $1,185,000 | -42.5% | 29,202 | +33.7% | 0.05% | -25.4% |
| Q1 2015 | $2,060,000 | -66.8% | 21,848 | -60.5% | 0.07% | -69.4% |
| Q4 2014 | $6,204,000 | – | 55,377 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |